Elevance Health, Inc. (ELV) — 分析摘要
Elevance Health, Inc.(ELV)的市值为92.33十亿美元,最近一年的营收同比增长了+14.2%。净利润率为3.4%。当前市盈率为17.6倍。
核心要点
- 营收同比变化+14.2%
- 净利润率3.4%
- 市盈率17.6倍
与HOSPITAL & MEDICAL SERVICE PLANS板块的其他公司相比,ELV的营收增长为+14.2%,市盈率为17.6倍。
Elevance Health, Inc. (ELV)
更新 — ET · 来源 POLYGON
红旗与风险提示重点关注
当前存在需要关注的风险信号,应与估值结果一并解读。
Debt/EBITDA 为 4.1x — 杠杆偏高
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
行业
HOSPITAL & MEDICAL SERVICE PLANS
员工人数
97,100
总部
INDIANAPOLIS, IN
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$6.88
股息收益率
1.61%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。